Landscapes / Companies
MorphoSys AG not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
0 active
5 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Incyte Corporation |
Approved | 29 Aug 2027Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 29 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Diffuse Large B-cell Lymphoma, Non Hodgkins Lymphoma and 5 more | ||||
| Open drug page | |||||
About
- No active trial
- MOR03087
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021